The group kicks off a new series on DLBCL, starting with the basics that come before disease management. The Fellow on Call group characterizes HIT, discusses the risk factors for HIT antibody formation, and much more. The Fellow on Call Podcast team shifts their focus from types 1 and 3 vWD to type 2 subtypes and how to manage them. The Fellow on Call team continues their series on hematology consultation with an overview of von Willebrand disease. Kaele Leonard, a pulmonary/critical care fellow who was diagnosed with breast cancer at a young age, discusses her journey. The Fellow on Call: The Heme/Onc Podcast covers HER2-positive breast cancer in part 11 of its series on breast cancer types. The Fellow on Call: The Heme/Onc Podcast switches from localized breast cancers to metastatic subtypes, starting with ER+. The Fellow on Call Podcast shifts its breast cancer focus to the triple-negative subtype. The Fellow on Call Podcast shifts their focus from ER+ to HER+ breast cancer, detailing treatment options, and much more. The Fellow on Call group continues discussing the management of early stage ER+/HER2-breast cancer. Part one of a two-part discussion on early stage ER+/HER2- breast cancer. Dr. Danielle Roman joins The Fellow on Call group to discuss pharmacology advancements in breast cancer. Dr. Carla Fisher details the nuances of surgical management for breast cancer. The Fellow on Call group clarifies the many complicated terms used in breast cancer. Radiation oncology resident Dr. Ryan Miller discusses the critical role of radiation therapy in breast cancer management. Dr. Yasha Gupta joins the group to elucidate the role breast radiologists play in diagnosing and treating this malignancy. The group makes the distinction between non-small cell lung cancer, used as an umbrella term, and small cell lung cancer. Drs. Matthew Abrahamson, Timothy Yau, and Scott Stockholm discuss immune checkpoint inhibitor-related acute kidney injuries. Lung cancer is one of the most common and deadly malignancies found in oncology, making early detection critical. The third episode in this series answers: What do you do when performing a biopsy on a suspected metastatic lesion?